China Resources Double-Crane Pharmaceutical Co Ltd (600062) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China.

Total Revenue Chart for China Resources Double-Crane Pharmaceutical Co Ltd

China Resources Double-Crane Pharmaceutical Co Ltd (600062) revenue for FY2025 was CNY 11.0B, a -1.9% change from FY2024. China Resources Double-Crane Pharmaceutical Co Ltd's revenue grew from CNY 156.7M in 1994 to CNY 11.0B in 2025 (6919.2% over 31 years). Earnings per share grew from CNY 0.17 in 2000 to CNY 0.90 in 2021 (430.3%). Revenue compound annual growth rate: 5-year CAGR of 5.3%, 10-year CAGR of 7.9%, 20-year CAGR of 4.5%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (CNY)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
¥16.75B
Implied Share Price
¥16.13
Enterprise Value
¥15.26B
Revenue (TTM)
¥10.73B
EBITDA
¥2.41B
Profit Margin
15.15%
Trailing P/E
10.34
Forward P/E
12.35
Price/Book (MRQ)
1.37
Price/Sales (TTM)
1.56
EV/EBITDA
5.78
EV/Revenue
1.41
Dividend Yield
0.00%
Book Value
¥11.26
Free Cash Flow (FY2025)
¥869.88M
Free Cash Flow Yield
5.19%

Snapshot as of 27th August 2026 — not point-in-time controlled, may lag the live market by a few days.